Interferon alpha-2b (Biolex)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha-2b (Biolex)
Drug Alias NameBLX-883
ClassificationBiologics
Mechanisms of ActionInterferon alpha stimulants
TargetsInterferon alpha
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiolex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolex
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A